Insights

Expanding Patents Longeveron holds multiple patents across the US, Canada, and Japan for its mesenchymal stem cell therapies and methods, indicating strong intellectual property protections that support potential licensing deals or partnerships in international markets.

Regenerative Focus The company's emphasis on cellular therapies for aging-related conditions and rare pediatric diseases presents opportunities to position their innovative treatments to healthcare providers specializing in geriatrics, neurology, and pediatric cardiology.

Strategic Incentives Recognition by regulators such as the FDA with orphan, rare pediatric disease, and fast-track designations for laromestrocel can facilitate faster approval processes, opening avenues to expedite market entry and sales in the U.S. and collaborate with payers focused on unmet medical needs.

Recent Advancements Longeveron’s recent patent grants and positive clinical trial momentum, including pivotal Phase 2b results anticipated in 2026, highlight their growing credibility and potential readiness for commercialization in select indications, encouraging early partnership or distribution opportunities.

Market Positioning With a focus on aging-related conditions and pediatric diseases, Longeveron can tailor sales strategies toward specialized clinics, geriatric centers, and pediatric healthcare providers that target unmet needs in aging and rare diseases, creating opportunities for early adoption and collaborative development.

Longeveron Inc Tech Stack

Longeveron Inc uses 8 technology products and services including MySQL, React, RequireJS, and more. Explore Longeveron Inc's tech stack below.

  • MySQL
    Database
  • React
    Javascript Frameworks
  • RequireJS
    Javascript Frameworks
  • Slick
    Javascript Libraries
  • Swiper
    Javascript Libraries
  • Priority Hints
    Performance
  • All in One SEO
    Search Engines
  • reCAPTCHA
    Security

Media & News

Longeveron Inc's Email Address Formats

Longeveron Inc uses at least 1 format(s):
Longeveron Inc Email FormatsExamplePercentage
FLast@longeveron.comJDoe@longeveron.com
48%
First@longeveron.comJohn@longeveron.com
2%
FLast@longeveron.comJDoe@longeveron.com
48%
First@longeveron.comJohn@longeveron.com
2%

Frequently Asked Questions

Where is Longeveron Inc's headquarters located?

Minus sign iconPlus sign icon
Longeveron Inc's main headquarters is located at 1951 Northwest 7th Avenue Miami, Florida United States. The company has employees across 2 continents, including North AmericaEurope.

What is Longeveron Inc's phone number?

Minus sign iconPlus sign icon
You can contact Longeveron Inc's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Longeveron Inc's stock symbol?

Minus sign iconPlus sign icon
Longeveron Inc is a publicly traded company; the company's stock symbol is LGVN.

What is Longeveron Inc's official website and social media links?

Minus sign iconPlus sign icon
Longeveron Inc's official website is longeveron.com and has social profiles on LinkedIn.

What is Longeveron Inc's SIC code NAICS code?

Minus sign iconPlus sign icon
Longeveron Inc's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Longeveron Inc have currently?

Minus sign iconPlus sign icon
As of March 2026, Longeveron Inc has approximately 39 employees across 2 continents, including North AmericaEurope. Key team members include Chief Technology Officer: D. B.Vp Corporate Controller: M. W.Vice President Of Technical Operations: J. L.. Explore Longeveron Inc's employee directory with LeadIQ.

What industry does Longeveron Inc belong to?

Minus sign iconPlus sign icon
Longeveron Inc operates in the Biotechnology Research industry.

What technology does Longeveron Inc use?

Minus sign iconPlus sign icon
Longeveron Inc's tech stack includes MySQLReactRequireJSSlickSwiperPriority HintsAll in One SEOreCAPTCHA.

What is Longeveron Inc's email format?

Minus sign iconPlus sign icon
Longeveron Inc's email format typically follows the pattern of FLast@longeveron.com. Find more Longeveron Inc email formats with LeadIQ.

How much funding has Longeveron Inc raised to date?

Minus sign iconPlus sign icon
As of March 2026, Longeveron Inc has raised $4.6M in funding. .

When was Longeveron Inc founded?

Minus sign iconPlus sign icon
Longeveron Inc was founded in 2014.

Longeveron Inc

Biotechnology ResearchFlorida, United States11-50 Employees

We are a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions. Our lead investigational product is laromestrocel (Lomecel-B™), which is derived from culture-expanded mesenchymal stem cells (MSCs) that are sourced from bone marrow of young healthy adult donors. We believe that by using the same cells that promote tissue repair, organ maintenance, and immune system function, we can develop safe and effective therapies for some of the most difficult diseases and conditions associated with aging.
Our clinical development programs have delivered several positive initial results across 5 clinical trials in 3 indications:  Phase 1 & 2 in Alzheimer’s Disease, Phase 1 & 2 in Aging-related Frailty, Phase 1 in Hypoplastic Left Heart Syndrome (HLHS), a rare pediatric disease.  We are currently conducting a pivotal Phase2b clinical trial in HLHS. Our mission is to advance laromestrocel (Lomecel-B™) and other cell-based product candidates into pivotal trials, with the goal of achieving regulatory approvals, subsequent commercialization and broad use by the healthcare community.
Our philosophy is that healthy aging can be improved through regenerative medicine approaches. Life expectancy has substantially increased over the past century as a result of medical and public health advancements. However, this increase in longevity has not been paralleled by the number of years a person is expected to live in relatively good health, free of chronic disease and disabilities of aging – a period known as healthspan. As we age, we experience a profound decline, in both number and function, in our own MSCs, a decrease in immune system function, decline in blood vessel functioning, chronic inflammation and other issues. Our clinical data suggest that laromestrocel (Lomecel-B™) addresses these conditions through multiple mechanisms of action, or MOAs, that target key aging-related processes

Section iconCompany Overview

Headquarters
1951 Northwest 7th Avenue Miami, Florida United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
LGVN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
11-50

Section iconFunding & Financials

  • $4.6M

    Longeveron Inc has raised a total of $4.6M of funding over 2 rounds. .

  • $1M

    Longeveron Inc's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $4.6M

    Longeveron Inc has raised a total of $4.6M of funding over 2 rounds. .

  • $1M

    Longeveron Inc's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.